Access closes in on EMED acquisition in deal to unite teleradiology vendorsPurchase would create teleradiology powerhouse Consolidation in the PACS and teleradiology market appears to be continuing. Teleradiology and miniPACS provider
Purchase would create teleradiology powerhouse
Consolidation in the PACS and teleradiology market appears to be continuing. Teleradiology and miniPACS provider Access Radiology has submitted an offer to acquire teleradiology and PACS firm EMED from its parent Raytheon. Knowledgeable sources say that the deal is expected to close before this month's Radiological Society of North America meeting.
Both companies declined to comment, but Access has scheduled a press conference at the show to announce acquisition of a major teleradiology supplier. The deal, if it goes through, would create a dominant presence in the diagnostic teleradiology marketplace.
Access is interested in EMED because of the San Antonio firm's extensive installed base of at-home teleradiology users. Access would be able to market its wide-area networking teleradiology products to these customers, sources say.
In addition, Access will gain EMED's distribution channels. Access currently sells its products through a direct sales force and through OEM partners such as GE Medical Systems, Sterling Diagnostic Imaging, and HBO & Company. EMED, on the other hand, markets its offerings in the U.S. through a small direct sales force and a distributor network. The company also has an international distributor presence, which Access does not. That was also a key factor in the Lexington, MA-based firm's interest, sources say.
Access would also seem to broaden its technology with the acquisition, evolving from a teleradiology and miniPACS provider to more of a high-end PACS player. EMED's PACS technology, however, did not appear to be a strong factor in the company's interest. Access will probably continue its focus on the diagnostic teleradiology market, while growing its capabilities in the miniPACS realm, sources say.
Access would also receive EMED's MegaScan monitor product line, which is marketed through other PACS firms on an OEM basis. Access would maintain EMED's operations in San Antonio, sources say.
For EMED, the deal would mark the end of its independent identity as a company that has played a strong role in the teleradiology market. EMED was formed in 1994 by defense firm E-Systems to include the consolidated operations of teleradiology market leaders Image Data and Advanced Video Products, which E-Systems bought in 1994 and 1992, respectively. E-Systems was in turn purchased by Raytheon in April 1995. Following the Raytheon deal, speculation arose regarding EMED's status at Raytheon. Some market watchers believed that Raytheon would rather spin off the company than maintain a small healthcare business outside its core defense operations.
In the past year, EMED has sought to make use of its hefty teleradiology installed base for PACS sales. The company has had limited success, however, landing only a small number of contracts.
The deal would be a winner for both sides. Access would be positioned as the industry leader in the two major teleradiology markets: remote primary diagnosis and at-home teleradiology, said Michael Cannavo, president of Image Management Consultants of Winter Springs, FL.
"It should also make Access more desirable as a potential acquisition by one of the major companies, if Access chooses to go that route," he said.
Key Chest CT Parameters for Body Composition May be Prognostic for Patients with Resectable NSCLC
February 11th 2025A high intermuscular adipose index has a 49 percent increased likelihood of being associated with lower overall survival in patients with resectable non-small cell lung cancer (NSCLC), according to new research.
Comparative AI Study Shows Merits of RapidAI LVO Software in Stroke Detection
February 6th 2025The Rapid LVO AI software detected 33 percent more cases of large vessel occlusion (LVO) on computed tomography angiography (CTA) than Viz LVO AI software, according to a new comparative study presented at the International Stroke Conference (ISC).